Recent patent rulings can impede the progress of personalized medicine: The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable

Michael R. Samardzija

Recent patent rulings can impede the progress of personalized medicine: The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Pages (from-to)	74
Number of pages	1
Journal	BioPharm International
Volume	22
Issue number	8
State	Published - Aug 2009

ASJC Scopus Subject Areas

Biotechnology
Pharmaceutical Science

OpenUrl availability

Full text

Cite this

@article{6651286b40b74ddcbfd53fe3fea119c2,

title = "Recent patent rulings can impede the progress of personalized medicine: The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable",

author = "Samardzija, {Michael R.}",

year = "2009",

month = aug,

language = "English",

volume = "22",

pages = "74",

journal = "BioPharm International",

issn = "1542-166X",

number = "8",

}

TY - JOUR

T1 - Recent patent rulings can impede the progress of personalized medicine

T2 - The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable

AU - Samardzija, Michael R.

PY - 2009/8

Y1 - 2009/8

UR - http://www.scopus.com/inward/record.url?scp=77951636269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951636269&partnerID=8YFLogxK

M3 - Short survey

AN - SCOPUS:77951636269

SN - 1542-166X

VL - 22

SP - 74

JO - BioPharm International

JF - BioPharm International

IS - 8

ER -

Recent patent rulings can impede the progress of personalized medicine: The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable

ASJC Scopus Subject Areas

OpenUrl availability

Other files and links

Cite this